Cited 2 times since 2005 (0.1 per year) source: EuropePMC The American journal of cardiology, Volume 95, Issue 10, 1 1 2005, Pages 1223-1225 Myocardial technetium-99m-tetrofosmin single-photon emission computed tomography compared with 18F-fluorodeoxyglucose imaging to assess myocardial viability. Schinkel AF, Bax JJ, Biagini E, Elhendy A, van Domburg RT, Valkema R, Rizzello V, Schouten O, Simoons M, Poldermans D
Technetium-99m-tetrofosmin single-photon emission computed tomography at rest is practical for routine assessment of viability in patients with ischemic cardiomyopathy. However, underestimation of viability may occur compared with 18F-fluorodeoxyglucose single-photon emission computed tomography, especially in the inferoposterior and septal regions.
